Company Overview
Polybalm is an evidence-based cancer care company dedicated to addressing one of cancer therapy's most overlooked side effects: nail damage. We deliver three integrated solutions—patient education, professional development, and a clinically proven product—to support cancer patients and healthcare professionals.

What We Do
We partner with cancer nurses, healthcare professionals, and NHS organisations to:
•	Provide high-quality patient education materials in 400+ hospitals
•	Deliver accredited CPD training mapped to ACCEND
•	Supply clinically proven products that stop and repair cancer therapy nail damage
•	Close the evidence-practice gap in cancer nail care

Why We're Different
•	Evidence-based: Grounded in a 1,352-patient survey and rigorous clinical trials
•	Comprehensive: Three integrated solutions addressing patient, nurse, and product needs
•	Credible: ACCEND-mapped CPD course and clinical trial data
•	Partnerships: Growing collaborations with UKONS, Cancer Alliances, and RCN
•	Impact: 300+ hospital visits in 18 months, 400+ hospitals stocking materials

Our Team
Polybalm brings together expertise in patient centred cancer nail care and innovation. We're a small but ambitious team dedicated to improving cancer nail care outcomes.

Get Involved

Learning: Take our ACCEND-mapped CPD course at https://cpd.polybalm.com/courses/recognising-and-managing-nail-damage-during-cancer-therapy/

Patient Resources: Order evidence-based patient booklets at https://polybalm.com/order-booklets

Clinical Evidence: Download our clinical trial data at https://polybalm.com/the-poly-balm-study

Hospital Partnership: Contact us to bring cancer nail care education to your healthcare system at care@polybalm.com

Product Information: Learn more about Polybalm at https://polybalm.com

Let's connect if you're passionate about improving cancer nail care outcomes

Polybalm

Org chart

Teams

Offices